Bron A, Chapard J, Creuzot-Garcher C, Guerzider V, D'Athis P
Service d'Ophtalmologie, CHU Dijon.
J Fr Ophtalmol. 1999 Mar;22(2):160-8.
We evaluated the accuracy and the reproducibility of central corneal thickness measurements using an ultrasound pachymeter, and its usefulness in clinical practice.
We calculated the intra-observer, inter-observer, and inter-session variability in control subjects (n = 38). We observed the diurnal variation (n = 8) and the role of surgery (n = 12) on central corneal thickness. We measured and compared central corneal thickness and intraocular pressure in 6 groups (control subjects n = 134, primary open-angle glaucoma n = 111, ocular hypertension n = 66, normal tension glaucoma n = 12, diabetes mellitus n = 62, corneal graft n = 27). We studied the influence of dorzolamide on central corneal thickness (n = 16).
The intra-observer variability was 9 +/- 4 microns, whereas the inter-observer and inter-session variabilities were 4 microns and 5% m respectively. The central corneal thickness in patients with ocular hypertension (587 +/- 41 microns) was significantly greater than control subjects (548 +/- 32 microns) and all the other groups (p < 0.001). No influence of dorzolamide was observed on central corneal thickness.
Central corneal thickness assessed with an ultrasound pachymeter may be a useful and accurate method in selected patients whose intraocular pressure measurement does not correlate with other clinical findings.
我们评估了使用超声角膜测厚仪测量中央角膜厚度的准确性、可重复性及其在临床实践中的实用性。
我们计算了对照组受试者(n = 38)的观察者内、观察者间和测量期间的变异性。我们观察了昼夜变化(n = 8)以及手术(n = 12)对中央角膜厚度的影响。我们测量并比较了6组受试者的中央角膜厚度和眼压(对照组n = 134、原发性开角型青光眼n = 111、高眼压症n = 66、正常眼压性青光眼n = 12、糖尿病n = 62、角膜移植n = 27)。我们研究了多佐胺对中央角膜厚度的影响(n = 16)。
观察者内变异性为9±4微米,而观察者间变异性和测量期间变异性分别为4微米和5%m。高眼压症患者的中央角膜厚度(587±41微米)显著大于对照组受试者(548±32微米)及所有其他组(p < 0.001)。未观察到多佐胺对中央角膜厚度有影响。
对于眼压测量与其他临床发现不相关的特定患者,使用超声角膜测厚仪评估中央角膜厚度可能是一种有用且准确的方法。